“…Pre-treatment agents include pervanadate, a tyrosine phosphatase inhibitor that leads to accumulation of phosphotyrosines (Amanchy, Kalume, Iwahori, Zhong, & Pandey, 2005;Rush et al, 2005), ionizing radiation (Matsuoka et al, 2007), nocodazole (Beausoleil et al, 2006), tumor necrosis factor-alpha (TNF-α) (Cantin et al, 2006) and epidermal growth factor (EGF) (Olsen et al, 2006). In order to compare treated with untreated cells, SILAC, stable isotope labeling with amino acids in cell culture, is frequently used (Ong et al, 2002).…”